Author:
Cho Hyun-Jeong,Kittaka Ryuichi,Abdou A. M.,Kim Mujo,Kim Hyeong-Soo,Lee Dong-Ha,Park Hwa-Jin
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Drug Discovery,Molecular Medicine
Reference44 articles.
1. Beavo, J. A., Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol. Rev., 75, 725–748 (1995).
2. Berger, P. B., Clopidogrel after coronary stenting. Curr. Intervent. Cardiol. Rep., 1, 263–269 (1999).
3. Berridge, M. J., The interaction of cyclic nucleotides and calcium in the control of cellular activity. Adv. Cyclic Nucleotide. Res., 6, 1–98 (1975).
4. Cannon, C., Mccabe, C., Borzak, S., Henry, T. D., Tischler, M. D., Mueller, H. S., Feldman, R., Palmeri, S. T., Ault, K., Hamilton, S. A., Rothman, J. M., Novotny, W. F., and Braunwald, E., Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI12 trial. Circulation, 97, 340–349 (1998).
5. Cavallini, L., Coassin, M., Borean, A., and Alexandre, A., Prostacyclin and sodium nitroprusside inhibit the activity of the platelet inositol 1,4,5-trisphosphate receptor and promote its phosphorylation. J. Biol. Chem., 271, 5545–5551 (1996).
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献